This is a news story, published by MSN, that relates primarily to AI news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from MSN, you can click here:
more news from MSNOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Enveda Biosciences. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest many modern pharmaceuticals news, Drug Discovery news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Recursion PharmaceuticalsDigital Market Reports
•80% Informative
Enveda Biosciences leverages AI to delve into chemistry of plants, aiming to discover new therapeutic agents.
The company’s AI technology identifies plants with the highest potential for therapeutic use, after which the identified materials are tested through the company's proprietary AI model.
Two of its drugs, aimed at treating eczema and inflammatory bowel diseases, are scheduled to enter clinical trials later this year .
VR Score
76
Informative language
74
Neutral language
31
Article tone
formal
Language
English
Language complexity
73
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
3
Source diversity
3
Affiliate links
no affiliate links